Unusual Skin Carcinomas Induced by BRAF Inhibitor for Metastatic Melanoma: A Case Report

The most frequently reported skin tumours during treatment with targeted therapies for BRAF (B type Rapidly Accelerated Fibrosarcoma kinase) mutated metastatic melanoma are squamous cell carcinomas (SCCs). Basal cell carcinomas (BCCs) have been described in such setting, but no cases of multiple and...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Clin Diagn Res
Glavni autori: Cavalieri, Stefano, Di Guardo, Lorenza, Cossa, Mara, Cimminiello, Carolina, Del Vecchio, Michele
Format: Artigo
Jezik:Inglês
Izdano: JCDR Research and Publications (P) Limited 2017
Teme:
Oncology Section
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5583902/
https://ncbi.nlm.nih.gov/pubmed/28893027
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7860/JCDR/2017/26881.10200
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items